CA
CHI Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-200,000
| Closed | -$458K | – | 27 |
|
|
2023
Q2 | $458K | Sell |
200,000
-2,139,402
| -91% | -$4.9M | 0.14% | 24 |
|
|
2023
Q1 | $2.13M | Sell |
2,339,402
-45,000
| -2% | -$41K | 0.57% | 20 |
|
|
2022
Q4 | $2.03M | Hold |
2,384,402
| – | – | 0.54% | 18 |
|
|
2022
Q3 | $1.95M | Buy |
2,384,402
+170,218
| +8% | +$139K | 0.52% | 22 |
|
|
2022
Q2 | $2.19M | Buy |
2,214,184
+511,047
| +30% | +$506K | 0.84% | 21 |
|
|
2022
Q1 | $2.79M | Buy |
1,703,137
+1,303,137
| +326% | +$2.14M | 1.19% | 19 |
|
|
2021
Q4 | $964K | Buy |
400,000
+234,073
| +141% | +$564K | 0.32% | 20 |
|
|
2021
Q3 | $803K | Sell |
165,927
-553,205
| -77% | -$2.68M | 0.23% | 15 |
|
|
2021
Q2 | $1.92M | Buy |
719,132
+40,000
| +6% | +$107K | 0.45% | 15 |
|
|
2021
Q1 | $2.09M | Buy |
679,132
+188,255
| +38% | +$580K | 0.42% | 14 |
|
|
2020
Q4 | $1.75M | Sell |
490,877
-92,355
| -16% | -$329K | 0.49% | 13 |
|
|
2020
Q3 | $2.34M | Buy |
583,232
+219,100
| +60% | +$879K | 0.83% | 12 |
|
|
2020
Q2 | $990K | Hold |
364,132
| – | – | 0.39% | 15 |
|
|
2020
Q1 | $768K | Sell |
364,132
-6,175
| -2% | -$13K | 1.81% | 9 |
|
|
2019
Q4 | $2.01M | Sell |
370,307
-20,000
| -5% | -$109K | 1.52% | 6 |
|
|
2019
Q3 | $1.18M | Buy |
+390,307
| New | +$1.18M | 1.14% | 7 |
|